Early Combined Immunosuppression Treatment in Crohn’s Disease Found to Improve Disease Course

Early Combined Immunosuppression Treatment in Crohn’s Disease Found to Improve Disease Course
A new study recently published in the journal The Lancet revealed that early combined immunosuppression (ECI) treatment can improve the disease course in patients with Crohn’s disease. The study is entitled “Early combined immunosuppression for the management of Crohn’s disease (REACT): a cluster randomised controlled trial”, and was led by researchers at the Robarts Research

Knowledge is power when living with IBD.

Get access to the web’s leading IBD news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

Leave a Comment

Your email address will not be published. Required fields are marked *